Skip to main content
Premium Trial:

Request an Annual Quote

Randy Goodman

Cancer Genetics has named Randy Goodman its new director of reimbursement and clinical revenue cycle management. He previously served as project director for health economics, reimbursement strategy, and health care policy at Precision for Medicine, and from 2009 to 2011 he was senior director of global health economics and reimbursement strategy at ImpediMed. According to Cancer Genetics, Goodman also served as a healthcare reform policy consultant to the White House Office on Health Reform, and was a policy consultant to Presidents Clinton and Obama.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.